How Effectively Can Large Language Models Connect SNP Variants and ECG Phenotypes for Cardiovascular Risk Prediction?

Niranjana Arun Menon, Iqra Farooq, Yulong Li, Sara Ahmed, Yutong Xie, Muhammad Awais, Imran Razzak · 2025

Read How Effectively Can Large Language Models Connect SNP Variants and ECG Phenotypes for Cardiovascular Risk Prediction? by Niranjana Arun Menon, Iqra Farooq, Yulong Li, Sara Ahmed, Yutong Xie, Muhammad Awais, Imran Razzak (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/arxiv-2508-07127.txt.

Introduction

Niranjana Arun Menon and co-authors test in 2025 how well large language models can link gene variants to heart readings for risk forecasting. Heart disease has many causes, and gene plus tracing data are rich but noisy and sparsely labeled. The team fine-tuned language models on profiles built from inherited gene markers and heart tracing traits.

Framed as a step-by-step reasoning task, the models named likely diseases and spelled out their clinical reasoning for each patient profile. Results varied, but the approach showed promise for early detection and risk sorting. The authors see a path toward more personal heart care, while noting the data hurdles that remain.

Catalog record

CREATORNiranjana Arun Menon, Iqra Farooq, Yulong Li, Sara Ahmed, Yutong Xie, Muhammad Awais, Imran Razzak
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE35 KB
VERSION1.0
LICENSEhttp://creativecommons.org/licenses/by/4.0/
RIGHTSCC BY
SOURCEarXiv

Source: https://arxiv.org/abs/2508-07127

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

How Effectively Can Large Language Models Connect SNP Variants and ECG Phenotypes for Cardiovascular Risk Prediction? Niranjana Arun Menon, Iqra Farooq, Yulong Li, Sara Ahmed, Yutong Xie, Muhammad Awais, Imran Razzak Abstract Cardiovascular disease (CVD) prediction remains a tremendous challenge due to its multifactorial etiology and global burden of morbidity and mortality. Despite the growing availability of genomic and electrophysiological data, extracting biologically meaningful insights from such high-dimensional, noisy, and sparsely annotated datasets remains a non-trivial task. Recently, LLMs has been applied effectively to predict structural variations in biological sequences. In this work, we explore the potential of fine-tuned LLMs to predict cardiac diseases and SNPs potentially leading to CVD risk using genetic markers derived from high-throughput genomic profiling. We investigate the effect of genetic patterns associated with cardiac conditions and evaluate how LLMs can learn latent biological relationships from structured and semi-structured genomic data obtained by mapping genetic aspects that are inherited from the family tree. By framing the problem as a Chain of Thought (CoT) reasoning task, the models are prompted to generate disease labels and articulate informed clinical deductions across diverse patient profiles and phenotypes. The findings highlight the promise of LLMs in contributing to early detection, risk assessment, and ultimately, the advancement of personalized medicine in cardiac care. I Introduction Cardiovascular disease (CVDs) remain the most common cause of mortality globally. In 2023, approximately 20.5 million people died from CVDs [ 1 ] , accounting for about one-third of all global deaths. This marks a significant increase from the estimated 17.9 million CVD deaths in 2019. Early identification of high-risk patients and timely initiation of appropriate treatment are crucial in mitigating adverse health outcomes associated with CVD. Genome-wide association studies (GWAS) [ 2 ] has uncovered numerous single nucleotide polymorphisms (SNPs) linked to CVDs, many of which are located in non-coding regions of the genome. These genetic variations can influence gene activity by impacting transcription factor (TF) binding sites, potentially resulting in changes that affect cardiovascular traits or disease development. Gaining insight into which variants are involved and their impact on TF binding is essential for uncovering the molecular basis of these conditions. While inherited genetic variation has long been established as a foundational determinant of cardiovascular disease (CVD) susceptibility, emerging research such as the integrative multi-omics framework proposed by Nam et al. [ 3 ] and the systems-level phenotyping approach outlined by Yurkovich et al. [ 4 ] emphasizes the critical role of combining genomic data with dynamic phenotypic biomarkers, including electrocardiographic (ECG) features. Such integrative strategies are increasingly recognized for their potential to refine risk stratification, elucidate disease mechanisms, and enable more precise predictive modeling in complex trait disorders like CVD. Single nucleotide polymorphisms (SNPs) have been widely studied in relation to arrhythmias, myocardial infarction, and sudden cardiac death, yet the mechanistic links between these variants and electrophysiological manifestations remain poorly understood [ 5 ] . Understanding how specific variants impact electrophysiological processes could enhance risk stratification in arrhythmic patients. Fig. 1 : SNPs influence ECG intervals (PR, QRS, QT) across biological levels: (A) Chromatin—identify genes affected by coding or non-coding SNPs; (B) Cell—determine cell types expressing the gene; (C) Tissue—link gene expression to tissue electrophysiology and ECG phenotypes. Deciphering these relationships requires modeling complex interactions between genomic features and time-series cardiovascular ECG data. Recently, LLMs have shown transformative potential across natural language processing tasks and are now being increasingly explored in scientific domains for modeling structured and unstructured data. Recent work has also demonstrated that LLMs are capable of high-fidelity extraction of clinically relevant information from free-text electronic health records (EHRs). Gu et al. [ 6 ] applied zero-shot and few-shot prompting with general-purpose LLMs such as GPT-3.5 and GPT-4 to automate clinical concept recognition, temporal relation extraction, and patient outcome prediction across large-scale EHR datasets. Their study emphasizes the adaptability of LLMs to heterogeneous medical domains, even in the absence of task-specific fine-tuning. Although competitive with rule-based and supervised baselines, their findings also highlight key limitations such as hallucination risks and sensitivity to prompt phrasing. These insights motivate our inclusion of refined prompt engineering strategies and validation measures when using LLMs for structured genomic and ECG reasoning. In genomics, traditional statistical models such as GWAS or polygenic risk scores often fall short in capturing nonlinear relationships and epistatic interactions across the genome [ 7 ] . LLMs, by contrast, provide a scalable mechanism to encode long-range dependencies and positional context in biological sequences, potentially allowing for the discovery of complex genotype-phenotype relationships that would otherwise remain obscured. Leveraging LLMs for multimodal integration of SNP data and ECG-derived features offers a novel, interpretable framework for risk stratification and biomarker discovery. Moreover, advances in multimodal learning allow LLMs to uncover clinically relevant cross-modal patterns, making them well-suited for tasks such as CVD risk classification, variant prioritization, and waveform anomaly detection [ 8 ] [ cakal_cardiovascular_2023 ] . Despite progress in genetic and cardiac modeling separately, studies integrating both within a unified, explainable architecture remain sparse, which highlights an urgent need for comprehensive, interpretable, and scalable cardiogenomic models. Cardiovascular phenotyping, particularly through electrocardiogram (ECG) analysis, adds another dimension of complexity. ECG waveforms are temporally rich biosignals that reflect a wide spectrum of physiological and pathological cardiac states. When interpreted through neural architectures such as transformer-based models, ECG signals can reveal subclinical patterns of disease [ 9 ] . We explore the genomic underpinnings of cardiac conditions by analyzing genetic patterns that may contribute to disease susceptibility and progression. Specifically, our study evaluates the ability of large language models (LLMs) to uncover latent biological relationships embedded within both structured (e.g., variant call formats, annotated gene panels) and semi-structured genomic data (e.g., clinical notes, pedigree information). We explore different tokenization strategies for genetic markers (e.g., SNP IDs, genomic loci), data embeddings for biosignal-derived features, and prompt engineering for multimodal learning within transformer-based architectures. In addition to mapping gene-disease associations, we incorporate family-based genetic information to identify potential hereditary links and variant propagation patterns for each patient. To systematically evaluate model performance, we formulate the analysis as a series of classification tasks—ranging from predicting the presence of specific cardiac phenotypes to assessing patient-specific risk profiles based on inherited genetic variants. The results demonstrate that LLMs, when fine-tuned on multi-modal genomic data, can extract high-order latent representations from biological and physiological data streams, facilitating improved diagnostic performance and interpretability. Besides, it can effectively generalize across diverse patient cohorts and phenotypic presentations. This could democratize access to genomic diagnostics, where interpretability and computational tractability are often limiting factors. To this end, we have the following key contributions • Construct a harmonized cardiogenomic dataset by aligning high-resolution SNP genotyping data with ECG-derived morphological and temporal features extracted from the HPP, enabling joint modeling of genetic and electrophysiological profiles. • Fine-tune open-source large language models on tokenized biological sequences (SNP k-mers, haplotypes) and dense ECG signal embeddings using modality-aware positional encodings, enabling unified representation learning across disparate biomedical data types. • Conduct in-depth interpretability analyses by evaluating self-attention distributions and gradient-based feature attribution scores to uncover genomic loci and waveform segments predictive of cardiovascular disease risk, facilitating biologically meaningful insights. • Demonstrate the feasibility of LLMs as scalable, plug-and-play architectures for integrative

Read the complete text